Junan Guo
Keine laufenden Positionen mehr
Profil
Junan Guo worked as a Senior Director-Analytical & Quality Services at Curia Global, Inc. from 2009 to 2016.
He also worked as a Director-Analytical Development at Patheon, Inc. Dr. Guo holds a doctorate degree from the University of Western Ontario and undergraduate and graduate degrees from Beijing Normal University.
Ehemalige bekannte Positionen von Junan Guo
| Unternehmen | Position | Ende |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Corporate Officer/Principal | 01.11.2016 |
| PATHEON, INC. | Corporate Officer/Principal | - |
Ausbildung von Junan Guo
| University of Western Ontario | Doctorate Degree |
| Beijing Normal University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
